- Efficacy of therapy with pegylated interferon and ribavirin in patients with chronic HCV infection.2009 | First Faculty of Medicine
- Pegylated inteferon beta 1-a in clinical routine2019 | Second Faculty of Medicine
- Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH2009 | First Faculty of Medicine
- Plasmafiltration as a possible contributor to kinetic targeting of pegylated liposomal doxorubicin (PLD) in order to prevent organ toxicity and immunosuppression2016 | Faculty of Medicine in Hradec Králové
- Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma2016 | First Faculty of Medicine
- Pegylated interferons - really the best choice?2003 | First Faculty of Medicine
- Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia2022 | Publication without faculty affiliation
- Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach2022 | Publication without faculty affiliation
- Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.2008 | First Faculty of Medicine
- Extracorporeal elimination of circulating pegylated liposomal doxorubicin (PLD) to enhance the benefit of cytostatic therapy in platinum-resistant ovarian cancer patients2015 | Faculty of Medicine in Hradec Králové
- Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer2020 | Faculty of Medicine in Hradec Králové
- Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH +12009 | Faculty of Medicine in Hradec Králové
- Effects of Membrane PEGylation on Entry and Location of Antifungal Drug Itraconazole and Their Pharmacological Implications2017 | First Faculty of Medicine
- PEGylated gold nanoparticles: Stability, cytotoxicity and antibacterial activity2019 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Mathematics and Physics
- Enzyme replacement with PEGylated cystathionine beta-synthase ameliorates homocystinuria in murine model2016 | First Faculty of Medicine
- Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial2016 | First Faculty of Medicine
- Pegylated Liposomal Doxorubicin in Combination With Hyperthermia in the Treatment of a Case of Advanced Hepatocellular Carcinoma2002 | Faculty of Medicine in Hradec Králové
- Research Report University Hospital clinical trial EC-FV-06Publication without faculty affiliation
- Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study2019 | Second Faculty of Medicine
- Pegylated Liposomal Doxorubicin in Combination with Hyperthermia for Treatment of Skin Metastases of Breast Carcinoma: A Case Report2001 | Faculty of Medicine in Hradec Králové
- Single-Site Mutational Engineering and Following MonoPEGylation of the Human Lectin Galectin-2: Effects on Ligand Binding, Functional Aspects, and Clearance from Serum2013 | First Faculty of Medicine
- New era of management of patients with haemophilia - replacement therapy with coagulation factors VIII and IX with an extended half-life (EHL)2019 | Second Faculty of Medicine
- Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access program2014 | First Faculty of Medicine
- Febrile neutropenia - new notes on prophylaxis with growth factors of granulopoiesis2023 | Faculty of Medicine in Pilsen
- Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data2021 | Second Faculty of Medicine
- Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression2007 | First Faculty of Medicine
- Telaprevir2012 | Faculty of Medicine in Pilsen
- Therapy of chronic hepatitis C with simeprevir2015 | First Faculty of Medicine
- Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years2020 | Faculty of Medicine in Hradec Králové